Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Ferrous Ascorbate: Each participant will be given liquid formulation of ferrous ascorbate at 3mg/kg of elemental iron daily for total 3 months
Control Intervention1: Ferrous Sulphate: E
Sponsors
Intra-Mural Research Grant by University College of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: Iron deficiency anemia will be defined as hemoglobin less than 11 g/dL and categorized as per WHO definition with peripheral blood smear suggestive of microcytic hypochromic picture AND low mean corpuscular volume and low serum ferritin below 12 mcg/L in the absence of infection and below 30 mcg/L in the presence of infection
Exclusion criteria
Exclusion criteria: Children with anemia due to dimorphic or megalobastic blood picture in peripheral smear or apparent non-nutritional etiology of anemia (obvious bleeding or chronic hemolytic anemia or malignancies) or known or suspected chronic systemic disease or those who have received iron preparations during last 2 weeks or those who received blood/packed cell transfusion within last 3 months will be excluded
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of non-anemic children after 12 weeks of therapyTimepoint: 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of participants compliant to oral iron therapy in the two groups 2. Side effects experienced among the two groups. 3. Proportion of children having appetite recovery using 16-item ?Early Childhood Appetite and Satiety Tool (ECAST) ? at 1, 2 and 4 weeks. 4. Hb at baseline, 2, 8 and 12 weeks of therapy. 5. Serum ferritin level at baseline and week 12. Timepoint: 1, 2, 4, 8, 12 weeks | — |
Countries
India
Contacts
Public ContactAarushi Kharb
University College of Medical Sciences and Guru Teg Bahadur Hospital
Outcome results
None listed